Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus

Journal of Infectious Diseases

Volumn 195, Issue 7, 2007, Pages 1062-1070

  Lilleri, Daniele ^a   Fornara, Chiara ^a   Furione, Milena ^a   Zavattoni, Maurizio ^a   Revello, Maria Grazia ^a   Gerna, Giuseppe ^a  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CYTOMEGALOVIRUS; INTRAUTERINE INFECTION; PREGNANT WOMAN; PRIMARY INFECTION; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; T LYMPHOCYTE SUBPOPULATION; VERTICAL TRANSMISSION;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE TRANSMISSION, VERTICAL; FEMALE; FLOW CYTOMETRY; HUMANS; INFANT, NEWBORN; INTERFERON TYPE II; INTERLEUKIN-2; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 33947418134     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/512245     Document Type: Article

References (33)

1. Stagno S, Pass RF, Cloud G, et al. Primary cytomegalovirus infection in pregnancy: incidence, transmission to fetus, and clinical outcome. JAMA 1986; 256:1904-8.
2. Stagno S, Pass RF, Dworsky ME, et al. Congenital cytomegalovirus infection: the relative importance of primary and recurrent maternal infection. N Engl J Med 1982; 306:945-9.
3. Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986; 153:478-88.
4. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 1992; 166:1223-7.
5. Meyers JD, Flournoy N, Thomas ED. Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant. J Infect Dis 1980; 142:816-24.
6. Reusser P, Riddell S, Meyers JD, Greenberg PD. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 1991; 78:1373-80.
7. Hayes K, Alford C, Britt W. Antibody response to virus-encoded proteins after cytomegalovirus mononucleosis. J Infect Dis 1987; 156:615-21.
8. Rasmussen L, Matkin C, Spaete R, Pachl C, Merigan TC. Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans. J Infect Dis 1991; 164:835-42.
9. Klemola E, Kaariainen L. Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis. BMJ 1965; 2:1099-102.
10. Klemola E, Kaariainen L, von Essen R, Haltia K, Koivuniemi A, von Bonsdorff CH. Further studies on cytomegalovirus mononucleosis in previously healthy individuals. Acta Med Scand 1967; 182:311-22.
11. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992; 326:663-7.
12. Lilleri D, Gerna G, Fornara C, Lozza L, Maccario R, Locatelli F. Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplantation. Blood 2006; 108:1406-12.
13. Gerna G, Lilleri D, Fornara C, et al. Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation. Am J Transplant 2006; 6:2356-64.
14. + T cells in protection against CMV disease. Blood 2003; 101:2686-92.
15. Revello MG, Lilleri D, Zavattoni M, et al. Lymphoproliferative response in primary human cytomegalovirus infection (HCMV) infection is delayed in HCMV transmitter mothers. J Infect Dis 2006; 193:269-76.
16. Stern H, Hannington G, Booth J, Moncrieff D. An early marker of fetal infection after primary cytomegalovirus infection in pregnancy. BMJ 1986; 292:718-20.
17. Fernando S, Pearce JM, Booth JC. Lymphocyte responses and virus excretion as risk factors for intrauterine infection with cytomegalovirus. J Med Virol 1993; 41:108-13.
18. Lyons AB. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods 2000; 243:147-54.
19. + T cells by a novel method using monocyte-derived HCMV-infected immature dendritic cells. Eur J Immunol 2005; 35:1795-804.
20. Gerna G, Piccinini G, Genini E, et al. Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART. J Acquir Immune Defic Syndr 2001; 28:320-31.
21. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179:1109-18.
22. + T cells. J Gen Virol 2005; 86:275-84.
23. Revello MG, Zavattoni M, Sarasini A, Percivalle E, Simoncini L, Gerna G. Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy. J Infect Dis 1998; 177:1170-5.
24. Revello MG, Zavattoni M, Furione M, Lilleri D, Gorini G, Gerna G. Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections. J Infect Dis 2002; 186:553-7.
25. Revello MG, Sarasini A, Zavattoni M, Baldanti F, Gerna G. Improved prenatal diagnosis of congenital human cytomegalovirus infection by a modified nested polymerase chain reaction. J Med Virol 1998; 56:99-103.
26. Revello MG, Zavattoni M, Baldanti F, Sarasini A, Paolucci S, Gerna G. Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns. J Clin Virol 1999; 14:57-66.
27. Pass RF, Dworsky ME, Whitley RJ, August AM, Stagno S, Alford CA. Specific lymphocyte blastogenic responses in children with cytomegalovirus and herpes simplex virus infections acquired early in infancy. Infect Immun 1981; 34:166-70.
28. Zanghellini F, Boppana SB, Emery VC, Griffiths PD, Pass RF. Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J Infect Dis 1999; 180:702-7.
29. Starr SE, Tolpin MD, Friedman HM, Paucker K, Plotkin SA. Impaired cellular immunity to cytomegalovirus in congenitally infected children and their mothers. J Infect Dis 1979; 140:500-5.
30. Mannering SI, Morris JS, Jensen KP, et al. A sensitive method for detecting proliferation of rare autoantigen-specific human T cells. J Immunol Methods 2003; 283:173-83.
31. + T cells capable of antigen-specific expansion and effector functions. J Infect Dis 2005; 192:1362-71.
32. + T cell help. J Infect Dis 2004; 189:971-83.
33. Pantaleo G, Harari A. Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat Rev Immunol 2006; 6:417-22.